High sensitivity C-reactive protein implicates heterogeneous metabolic phenotypes and severity in metabolic dysfunction associated-steatotic liver disease
The study protocol was registered at the Chinese Clinical Trial Registry, (ChiCTR-ChiCTR2000034197), approved by the First Affiliated Hospital of Sun Yat-sen University institutional with the regional medical ethics committees (Approval number: [2020] No. 187), and performed in accordance with the ethical standards of the 1964 Declaration of Helsinki. Written informed consent was obtained from all the patients.
Authors
- Xin Li (ORCID: https://orcid.org/0000-0001-5422-3099)
- Xiaorong Gong (ORCID: https://orcid.org/0000-0001-5369-6089)
- Zhiyong Dong (ORCID: https://orcid.org/0000-0003-3795-3668)
- Junzhao Ye (ORCID: https://orcid.org/0000-0003-3163-4164)
- Bihui Zhong (ORCID: https://orcid.org/0000-0002-3089-8152)
- Hao Wang (ORCID: https://orcid.org/0000-0001-6881-9977)
- Lishu Xu (ORCID: https://orcid.org/0009-0007-1540-631X)
- Yanhong Sun (ORCID: https://orcid.org/0000-0003-1169-1831)
- Hong Deng
- Youpeng Chen (ORCID: https://orcid.org/0000-0002-9677-2333)
Institutions
- Sun Yat-sen University (CN)
- The Seventh Affiliated Hospital of Sun Yat-sen University (CN)
- First Affiliated Hospital of Guangzhou Medical University (CN)
- The First Affiliated Hospital, Sun Yat-sen University (CN)
- Guangdong Academy of Medical Sciences (CN)
- Third Affiliated Hospital of Sun Yat-sen University (CN)
- Guangdong Provincial People's Hospital (CN)
- First Affiliated Hospital of Jinan University (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- BMC Gastroenterology
- Published
- 2025-04-08
- DOI
- https://doi.org/10.1186/s12876-025-03778-2
- Citations
- 5
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 6.77
Funders
- National Natural Science Foundation of China
- Sun Yat-sen University
- Natural Science Foundation of Guangdong Province